CMPS peer analysis
COMPASS Pathways (CMPS) against its competitors: price, today's move, 1-year return and market value side by side.
CMPS and its peers
| Company | Price | Today | 1-year return | Market cap |
|---|---|---|---|---|
| ACAD Acadia Pharmaceuticals | $21.23 | -0.05% | -3.72% | $3.70B |
| DFTX Definium Therapeutics | $33.42 | 10.08% | – | – |
| DNLI Denali Therapeutics | $20.16 | 2.23% | 32.44% | $3.36B |
| GHRS GH Research | $18.61 | 0.92% | 35.69% | – |
| HRMY Harmony Biosciences | $33.00 | 1.63% | 3.57% | – |
| LBRX LB Pharmaceuticals | $42.50 | 11.58% | 135.12% | – |
| MPLT MapLight Therapeutics | $7.60 | 22.19% | -61.13% | – |
| NERV Minerva Neurosciences | $2.30 | -10.51% | -39.79% | $122.71M |
| PRAX Praxis Precision Medicines | $279.00 | 6.25% | 59.49% | – |
| RAPP Rapport Therapeutics | $24.44 | 3.04% | -9.48% | – |
| CMPS COMPASS Pathways | $8.75 | 12.04% | 46.08% | – |
- CMPS's peers: ACAD (Acadia Pharmaceuticals), DFTX (Definium Therapeutics), DNLI (Denali Therapeutics), GHRS (GH Research), HRMY (Harmony Biosciences), LBRX (LB Pharmaceuticals), MPLT (MapLight Therapeutics), NERV (Minerva Neurosciences).
Updated 2026-11-07 11:54 UTC